Phase II/III trial of topical interferon-alpha 2b in patients with cervical dysplasia.

Trial Profile

Phase II/III trial of topical interferon-alpha 2b in patients with cervical dysplasia.

Planning
Phase of Trial: Phase II/III

Latest Information Update: 11 Nov 2011

At a glance

  • Drugs Interferon alpha-2b (Primary)
  • Indications Cervical cancer; Cervical dysplasia
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 11 Nov 2011 Planned initiation date changed from 30 Jun 2010 to NULL.
    • 11 Nov 2011 The US FDA removes a clinical hold on an IND application for this trial, according to a Helix BioPharma media release.
    • 12 Oct 2011 Helix BioPharma has filed a complete response to the clinical hold, according to a Helix BioPharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top